Et cetera
Facial Recognition to Predict Protein-Protein Interactions
Machine learning could be a powerful new tool in the study of protein interactions. Computational biologist Bruno Correia at École Polytechnique Fédérale de Lausanne, has designed a new system for "molecular surface interaction fingerprinting" (MaSIF), which utilizes...
Clinical trials in the time of COVID-19
FDA has issued guidelines for the conduct of clinical trials during the COVID-19 pandemic. “With this guidance issued today, the FDA is helping industry and investigators navigate the COVID-19 pandemic and help assess how to move forward with critical clinical...
New website aggregates global COVID-19 information
Data scientists at Scripps Research in La Jolla, California launched a new website to boost SARS-CoV-2 / COVID-19 research data usability for all. The site Outbreak.info focuses on aggregating SARS-CoV-2 / COVID-19 metadata in a single site with the goal of making...
Another success story for phage to treat resistant infection
A collaboration between HHMI's SEA PHAGES program and physicians at London's Great Ormond Street Hospital result in the successful compassionate use of engineered bacteriophage to treat a drug resistant mycobacterium infection in a teenager who received a double lung...
Happy Earth Day
Team Somatek celebrated Earth Day with a hearty lunch of plant-based burgers from Beyond Meat. Very tasty indeed. Look for it in your local market https://www.beyondmeat.com
Mark Fitchmun speaks at AGC Global CMO Consultant Summit 2018
AGC Biologics is a global leader in clinical and commercial manufacturing of therapeutic proteins and held its 2018 Global CMO Consultant Summit from September 10-13, 2018. Mark presented a talk entitled “Instability of Biologics Following Transport”. The event...
Happy Summer!
Somatek wishes all associates, clients and friends a happy Independence Day, joyous Bastille Day, delicious National Ice Cream Day (July 15th : ) and, if you are watching, an exciting FIFA World Cup.
Mark Fitchmun visits Infors HT
Somatek is increasing its upstream capabilities to serve the needs of existing and future clients. The objective is to support research scale and manufacturing scale upstream processes and integrate those with Somatek’s establish core strengths in downstream and assay...
CAR-T Cells: Cool new poster
Got empty wall space in your lab or hallway? Consider decorating with the new timely “Chimeric Antigen Receptor (CAR)-T Cell in Immunotherapy” poster available from Novus Biologicals. https://www.novusbio.com This wall poster provides an overview of Chimeric Antigen...
Somatek launches new website
Somatek is pleased to announce the launch of its new website with improved functionality, fresh graphic design and new content. Many thanks to Sanne Wesselman and AtoZmarketing for expert support in setting up the new site. Please visit us often for updates and to see...